Skip to main content

Table 1 The clinical information of validation samples

From: Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis

Index

Classification

Case number

Percentage

(%)

Index

Classification

Case number

Percentage

(%)

Sex

male

37

69.80

Tumor differentiation status

high

1

1.89

female

16

30.20

medium

34

64.20

Age

<  60

24

45.28

low

12

22.61

≥ 60

28

52.83

None

6

11.30

None

1

1.90

Hypertension

Yes

20

37.70

Tumor stage

I-II

15

28.30

No

31

58.50

III-IV

36

67.90

None

2

3.80

None

2

3.80

Diabetes

Yes

5

9.40

Primary diagnosis

Mucinous adenocarcinoma

7

13.20

No

46

86.80

Other adenocarcinoma

44

83.00

None

2

3.80

None

2

3.80

Coronary heart disease

Yes

6

11.30

KPS score

80

3

5.70

No

45

84.90

90

23

43.40

None

2

3.80

95

12

22.60

Other diseases

Yes

15

28.30

None

15

28.30

No

36

67.90

Drinking habit

Yes

30

56.60

None

2

3.80

NO

12

22.60

Therapeutic method

Neoadjuvant chemotherapy + Operation

4

5.70

None

11

20.80

Operation only

24

45.30

Smoking habit

Yes

24

45.30

Operation + chemotherapy

23

43.40

NO

23

43.40

Neoadjuvant chemotherapy+Operation+Targeting

2

3.80

None

6

11.30

OS

<  1 year

17

32.08

Tumor size

<  5 cm

23

43.40

1–3 years

16

30.19

≥ 5 cm

26

49.10

≥ 3 years

5

9.43

None

4

7.50

None

5

9.43

  1. OS, survival time; None indicated unclear or unknown